<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder of the connective tissues, with mutation on the fibrillin-1 gene encoding for fibrillin, a major component of the extracellular microfibrils </plain></SENT>
<SENT sid="1" pm="."><plain>The prevalence of the syndrome is 7 to 17 in 100,000 </plain></SENT>
<SENT sid="2" pm="."><plain>The mean life expectancy for untreated patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is 32 years, with <z:hpo ids='HP_0002647'>aortic dissection</z:hpo>, <z:e sem="disease" ids="C0003496" disease_type="Disease or Syndrome" abbrv="">aortic rupture</z:e>, or <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> from mitral or <z:hpo ids='HP_0001659'>aortic valve regurgitation</z:hpo> as the predominant cause of <z:hpo ids='HP_0011420'>death</z:hpo> in &gt;90% of patients </plain></SENT>
<SENT sid="3" pm="."><plain>However, with optimal clinical management of patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, life expectancy may be improved substantially to a nearly <z:mpath ids='MPATH_458'>normal</z:mpath> life span </plain></SENT>
<SENT sid="4" pm="."><plain>Cornerstones of clinical management include modern noninvasive imaging modalities, molecular analysis at the complementary <z:chebi fb="9" ids="16991">deoxyribonucleic acid</z:chebi>/<z:chebi fb="9" ids="16991">deoxyribonucleic acid</z:chebi> level of the fibrillin-1 gene, genetic counseling, lifestyle changes, and cardiovascular surveillance, the latter including regular imaging of the aorta and <z:hpo ids='HP_0100584'>endocarditis</z:hpo> prophylaxis </plain></SENT>
<SENT sid="5" pm="."><plain>Prophylactic use of beta-blocking agents, the timing of elective surgery, and the optimal surgical technique are difficult issues that need to be evaluated individually </plain></SENT>
<SENT sid="6" pm="."><plain>Juvenile, postoperative, and pregnant patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> pose particular problems </plain></SENT>
<SENT sid="7" pm="."><plain>The goal of this review is to facilitate differential decision-making based on referenced evidence and to provide guidelines for medical and surgical therapeutic strategies </plain></SENT>
</text></document>